Arjun Mohan, MBBS
Clinical Associate Professor of Internal Medicine
Associate Chief Clinical Officer
Medical Specialties Oversight Team
[email protected]

Available to mentor
Arjun Mohan, MBBS
Clinical Associate Professor
  • Qualifications
  • Research Overview
  • Links
  • Recent Publications
    • Qualifications
    • Fellow
      University at Buffalo, New Yord, 2015
    • Resident
      Miller School of Medicine, Internal Medicine, 2012
    • MBBS
      J.J.M Medical College, Davangere, 2006
    Research Overview

    Dr. Mohan's research focuses on evaluating novel therapies in asthma. He has been an investigator for numerous clinical trials. His research interests also include understanding the heterogeneity of asthma, the performance of various available tools and developing predictive models for exacerbations and similar outcomes. Dr. Mohan has led large expert panels in projects to develop statements (guidelines) to better guide future research and hence, serve patients.

    Links
    • PubMed
    Recent Publications See All Publications
    • Journal Article
      Biologics in Asthma: Emerging Biologics.
      Desai B, Adrish M, Mohan A, Lugogo NL. Immunol Allergy Clin North Am, 2024 Nov; 44 (4): 751 - 763. DOI:10.1016/j.iac.2024.07.008
      PMID: 39389722
    • Journal Article
      BIOLOGIC OUTCOMES AMONG PATIENTS WITH SEVERE ASTHMA AND NORMAL LUNG FUNCTION: RESULTS FROM THE CHRONICLE STUDY
      PANETTIERI RA, LUGOGO NL, MOHAN A, LEDFORD DK, CARSTENS DD, AMBROSE CS. CHEST Journal, 2024 Oct; 166 (4): a4 - a7. DOI:10.1016/j.chest.2024.06.034
    • Journal Article
      DEVELOPMENT OF A NOVEL DASHBOARD UTILIZING DIGITAL INHALER DATA TO SUPPORT CLINICAL MANAGEMENT
      LUGOGO NL, DERSTINE B, GULATI M, MOHAN A, SENN R, HARWOOD H, HILL TD, BOE A, RUTLAND C, SULLIVAN J, SAFIOTI GG. CHEST Journal, 2024 Oct; 166 (4): a3924 - a3926. DOI:10.1016/j.chest.2024.06.2370
    • Journal Article
      A Novel Examination of Azithromycin as a Low-Cost Intervention to Achieve Remission in Asthma.
      Rhoads SL, Mohan A. Chest, 2024 Aug; 166 (2): 241 - 242. DOI:10.1016/j.chest.2024.06.003
      PMID: 39122292
    • Proceeding / Abstract / Poster
      A Real-world Experience With Tezepelumab as the First Biologic Option in Severe Asthma Patients
      Mohan A, Bagheri A, Senn R, Harwood H, Fergan J, Derstine B, Lugogo NL. 2024 May; a5392 - a5392. DOI:10.1164/ajrccm-conference.2024.209.1_meetingabstracts.a5392
    • Proceeding / Abstract / Poster
      A Real-world Experience on New Starts Versus Biological Switchers for Tezepelumab in Severe Asthma
      Mohan A, Senn R, Harwood H, Derstine B, Fergan J, Bagheri A, Lugogo NL. 2024 May; a5391 - a5391. DOI:10.1164/ajrccm-conference.2024.209.1_meetingabstracts.a5391
    • Proceeding / Abstract / Poster
      Greater Exacerbation Reductions With Earlier Biologic Initiation After Severe Asthma Onset: Results From the Chronicle Study
      Mohan A, Panettieri RA, Moore WC, Lugogo NL, Lindsley AW, Carstens DD, Ambrose CS. 2024 May; a6699 - a6699. DOI:10.1164/ajrccm-conference.2024.209.1_meetingabstracts.a6699
    • Proceeding / Abstract / Poster
      Impact of Adherence to Maintenance Therapy, as Measured Using Digital Inhaler Data, on Asthma Control and Healthcare Resource Utilization Among Patients Using Biologics
      Askar S, Harwood H, Mohan A, Derstine B, Gulati M, Hill TD, Boe A, Lugogo NL. 2024 May; a5373 - a5373. DOI:10.1164/ajrccm-conference.2024.209.1_meetingabstracts.a5373